G9137
HCPCSOnc dx nhl relapse/refractor
Official HCPCS Level II long descriptor
Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; relapsed/refractory (for use in a medicare-approved demonstration project)
HCPCS Level II code G9137 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Onc dx nhl relapse/refractor
Added to HCPCS: 2007-01-01
Nearby codes in G9
- G9129Onc dx mult myeloma stg2 hig
- G9130Onc dx multi myeloma unknown
- G9131Onc dx brst unknown nos
- G9132Onc dx prostate mets no cast
- G9133Onc dx prostate clinical met
- G9134Onc nhlstg 1-2 no relap no
- G9135Onc dx nhl stg 3-4 not relap
- G9136Onc dx nhl trans to lg bcell
- G9138Onc dx nhl stg unknown
- G9139Onc dx cml dx status unknown
- G9140Frontier extended stay demo
- G9143Warfarin respon genetic test
- G9147Outpt iv insulin tx any mea
- G9148Medical home level 1
- G9149Medical home level ii
- G9150Medical home level iii
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.